Murine models of brain aging and age-related neurodegenerative diseases

Behavioural Brain Research

Volumn 85, Issue 1, 1997, Pages 1-25

  Jucker, Mathias ^a,b   Ingram, Donald K ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Alzheimer's disease; CNS; knock out; lesion; mouse models; mutant; neurodegeneration; oxidative stress; selective breeding; senescence accelerated mouse; structural changes; transgenic

Indexed keywords

AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN INJURY; GLIOSIS; INFLAMMATION; MOUSE; MUTANT; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE;

AGING; ANIMALS; BRAIN; HUMANS; MICE; NERVE DEGENERATION; NERVOUS SYSTEM DISEASES; RATS;

EID: 0031056869     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(96)02243-7     Document Type: Review

References (262)

1. Aguzzi, A., Brandner, S., Sure, U., Ruedi, D. and Isenmann, S., Transgenic and knock-out mice: models of neurological disease, Brain Pathol., 4 (1994) 3-20.
2. Akiyama, H., Kameyama, M., Akiguchi, I., Sugiyama, T., Kawamata, H., Fukuyama, H., Kimura, H., Matsushita, M. and Takeda, T., Periodic acid Schiff (PAS)-positive, granular structures increase in the brains of Senescence Accelerated Mouse (SAM), Acta Neuropathol., 12 (1986) 124-129.
3. Ali, S.M., Siedlak, S.L., Gonzalez-DeWhitt, P.A., Altman, R.A., Glendening, J.M., Lowery, D.E., Savage, M.J., Polites, H.G., Perry, G. and Greenberg, B.D., Artifactual strain-specific signs of incipient brain amyloidosis in APP transgenic mice, Neurobiol. Aging, 17 (1996) 223-234.
4. Allore, R., O'Hanlon, D., Price, R., Neilson, K., Willard, H.F., Cox, O.R., Marks, A. and Dunn, R.J., Gene encoding the β subunit of S100 protein is on chromosome 21: implications for Down Syndrome, Science, 239 (1988) 1311-1313.
5. Amano, T., Nakanishi, H., Oka, M. and Yamamoto, K. Increased expression of cathepsins E and D in reactive microglial cells associated with spongiform degeneration in the brain stem of senescence-accelerated mouse, Exp. Neurol., 136 (1995) 171-182.
6. Andersen, J.K., Frim, D.M., Isacson, O. and Breakefield, X.O. Catecholaminergic cell atrophy in a transgenic mouse aberrantly overexpressing MAO-B in neurons, Neurodegeneration, 3 (1994) 97-109.
7. Andrew, W. and Winston-Salem, N.C., Structural alterations with aging in the nervous system, J. Chronic Dis., 3 (1957) 575-596.
8. Backhaub, C., Karkoutly, C., Welsch, M. and Krieglstein, J., A mouse model of focal cerebral ischemia for screening neuroprotective drug effects, J. Pharmacol. Methods, 27 (1992) 27-32.
9. Bankiewicz, K., Mandel, R.J. and Sofroniew, M.V., Trophism, transplantation, and animal models of Parkinson's disease, Exp. Neurol. 124 (1993) 140-149.
10. Barone, F.C., Knudsen, D.J., Nelson, A.H., Feuerstein, G.Z. and Willette, R.N., Mouse strain differences in susceptibility to cerebral ischemia are related to cerebral vascular anatomy, J. Cerebral Blood Flow Metabol., 13 (1993) 683-692.
11. Bereiter, D.A. and Jeanrenaud, B., Altered neuroanatomical organization in the central nervous system of the genetically obese (ob/ob) mouse, Brain Res., 165 (1979) 249-260.
12. Blackwell, B.N., Bucci, T.J., Hart, R.W. and Turturro, A., Longevity, body weight, and neoplasia an ad libitum-fed and diet-restricted C57BL/6 fed NIH-31 open formula diet, Toxicol. Pathol., 23 (1995) 570-582.
13. Brett, F.M., Mizisin, A.P., Powell, H.C. and Campbell, I.L., Evolution of neuropathological abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes, J. Neuropathol. Exp. Neurol., 54 (1995) 766-775.
14. Brizzee, K.R., Ordy, J.M., Hofer, H. and Kaack, B., Animal models for the study of senile brain disease and aging changes in the brain. In R. Katzman, R.D. Terry and K.L. Bick (Eds.), Alzheimer's Disease: Senile Dementia and Related Disorders (Aging), Vol. 7, 1978, Raven Press, New York, pp. 515-553.
15. Brody, H., Organization of the cerbral cortex. III. A study of aging in the human cerebral cortex, J. Comp. Neurol., 102 (1955) 511-556.
16. Bronson, R.T., Lipman, R.D. and Harrison, D.E., Age-related gliosis in the white matter of mice, Brain Res., 609 (1993) 124-128.
17. Buxbaum, J.D., Christensen, J.L., Ruefli, A.A., Greengard, P. and Loring, J.F., Expression of APP in brains of transgenic mice containing the entire human APP gene, Biochem. Biophys. Res. Comm., 197 (1993) 639-645.
18. Cai, X.-D., Golde, T.E. and Younkin. S.G., Release of excess amyloid β protein from a mutant amyloid β protein precursor, Science, 259 (1993) 514-516.
19. Calingasan, N.Y., Gandy, S.E., Baker, H., Sheu, K.F.R., Smith, J.D., Lamb, B.T., Gearhart, J.D., Buxbaum, J.D., Harper, C., Selkoe, D.J., Price, D.L., Sisodia, S.S. and Gibson, G.E., Novel neuritic clusters with accumulation of amyloid precursor protein and amyloid precursor-like protein 2 immunoreactivity in brain regions damaged by thiamine deficiency, Am. J. Pathol., 149 (1996) 1063-1071.
20. Campbell, I.L., Abraham, C.R., Masliah, E., Kremer, P., Inglis, J.D., Oldstone, M.B.A. and Mucke, L., Neurological disease induced in transgenic mice by cerebral overexpression of interleukin 6, Proc. Natl. Acad. Sci. USA, 90 (1993) 10 061-10 065.
21. Ceballos-Picot, I., Nicole, A., Clement, M., Bourre, J.-M., Sinet, P.-M., Age-related changes in antioxidant enzymes and lipid peroxidation in brains of control and transgenic mice overexpressing copper-zinc superoxide dismutase, Mutation Res., 275 (1992) 281-293.
22. Cecim, M., Ghosh, P.K., Esquifino, A.I., Began, T., Wagner, T.E., Yun, J.S. and Bartke, A., Elevated corticosterone levels in transgenic mice expressing human or bovine growth hormone genes, Neuroendocrinology, 53 (1991) 313-316.
23. Cerami, A., Hypothesis: Glucose as mediator of aging, J. Am. Geriatr. Soc., 33 (1985) 626-634.
24. Chua, S.C., Chung, W.K., Wu-Peng, X.S., Zhang, Y., Liu, S.M., Tartaglia, L. and Leibel, R.L., Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor, Science, 271 (1996) 994-996.
25. Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A.Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I. and Selkoe, D.J., Mutations of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production, Nature, 360 (1992) 672-674.
26. Coggeshall, R.E., Lekan, H.A., Methods for determining numbers of cells and synapses: A case for more uniform standards of review, J. Comp. Neurol., 364 (1996) 6-15.
27. Coleman, P.D., Buell, S.J., Magagna, L., Flood, D.G. and Curcio, C.A., Stability of dendrites in cortical barrels of C57BL/ 6N mice between 4 and 45 months, Neurobiol. Aging, 1 (1986) 101-105.
28. Coleman, P.D. and Flood, D.G., Neuron numbers and dendritic extent in normal aging and Alzheimer's disease, Neurobiol. Aging, 8 (1987) 521-545.
29. Committee on Standardized Genetic Nomenclature for Mice, Mouse Genome, 92 (1994) VIII-XXIII.
30. Connor, J.R. and Diamond, M.C., A comparison of dendritic spine number and type on pyramidal neurons on the visual cortex of old rats from social and isolated environments, J. Comp. Neurol., 210 (1982) 99-106.
31. Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L. and Pericak-Vance, M.A., Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261 (1993) 921-923.
32. Csete, K., Kovacs, G.L. and Szekeres, L., Disturbance of motoric function as behavioral measure of impaired cerebral circulation in mice, Physiol. Behav., 36 (1986) 409-412.
33. Curcio, C.A. and Coleman, P.D., Stability of neuron number in cortical barrels of aging mice, J. Comp. Neurol., 212 (1982) 158-172.
34. Davies, I. and Fotheringham, A.P., The influence of age on the hypothalamio-neurohypophyseal system of the mouse: a quantitative ultrastructural analysis of the supraoptic nucleus, Mech. Ageing Dev., 12 (1980) 93-105.
35. Davies, I. and Fotheringham, A.P., The influence of age on the response of the supraoptic nucleus of the hypothalamo-neurohypophyseal system to physiological stress. II Quantitative morphology, Mech. Ageing Dev., 15 (1981) 367-378.
36. Dear, K.B., Salazar, M., Watson, A.L., Gelman, R.S., Bronson, R. and Yunis, E.J., Traits that influence longevity in mice: a second look, Genetics., 132 (1992) 229-239.
37. DeKosky, S.T. and Scheff, S.W., Synapse loss in frontal cortex biobsies in Alzheimer's disease: Correlation with cognitive severity, Ann. Neurol., 21 (1990) 457-464.
38. DeKosky, S.T., Scheff, S.W. and Cotman, C.W., Elevated corticosterone levels; a possible cause of reduced axon sprouting in aged animals, Neuroendocrinology, 38 (1984) 33-38.
39. de la Torre, J.C., Treatment of head injury in mice using a fructose 1,6-diphosphate and dimethyl sulfoxide combination, Neurosurgery, 37 (1995) 273-279.
40. Diamond, M.C., Johnson, R.E., Protti, A.M., Ott, C. and Kajisa, L., Plasticity in the 904 day old male rat cerebral cortex, Exp. Neurol., 87 (1985) 309-317.
41. Dunnett, S.B. and Barth, M., Animal models of Alzheimer's disease and demetia. In P. Willner (Ed.), Behavioural Models in Psychopharmacology: Theoretical, Industrial, and Clinical Perspectives, 1991, Cambride University Press, Cambridge, pp. 359-418.
42. Eddleston, M. and Mucke, L., Molecular profile of reactive astrocytes-implications for their role in neurologic disease, Neuroscience, 54 (1993) 15-36.
43. Eikelenboom, P., Zhan, S.S., van Gool, W.A. and Allsop, D., Inflammatory mechanisms in Alzheimer's disease, Trends Pharmacol., 15 (1994) 447-450.
44. Epstein, C.J., Avraham, K.B., Lovett, M., Smith, S., Elroy-Stein, O., Rotman, G., Bry, C. and Groner, Y., Transgenic mice with increased Cu/Zn-superoxide dismutase activity: Animal model of dosage effects in Down syndrome, Proc. Natl. Acad. Sci. USA, 84 (1987) 8044-8048.
45. Ershler, W.B., Interleukin-6: A cytokine for gerontologists, J. Am. Geriatr. Soc., 41 (1993) 176-181.
46. Escorihuela, R.M., Fernandez-Teruel, A., Vallina, I.F., Baamonde, C., Lumbreras, M.A., Dierssen, M., Tobena, A. and Florez, J., A behavioral assessment of Ts65Dn mice: A putative Down Syndrome model, Neurosci. Lett., 199 (1995) 143-146.
47. Fattori, E., Lazzaro, D., Musiani, P., Modesti, A., Alonzi, T. and Ciliberto, G., IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage, Eur. J. Neurosci., 7 (1995) 2441-2449.
48. Feldman, J.M., Blalock, J.A. and Foster. L.B., Effects of food restriction on mice with hereditary obese-hyperglycemic syndrome, Acta Diabetol. Lat., 16 (1979) 27-33.
49. Finch, C.E., Neuron atrophy during aging: programmed or sporadic, TINS, 16 (1993) 104-110.
50. Fink, G.R., Zilles, K. and Schleicher, A., Postnatal development of the forebrain regions in the autoimmune NZB mouse. A model for degeneration in neuron systems, Anat. Embryol., 183 (1991) 579-588.
51. Flood, D.G. and Coleman, P.D., Neuron numbers and sizes in aging brain: Comparisons of human, monkey, and rodent data, Neurobiol. Aging, 9 (1988) 453-463.
52. Flood, J.F. and Morley, J.E., Early onset of age-related impairment of aversive and appetitive learning in the SAM-P/8 mouse, J. Gerontol., 47 (1992) B52-59.
53. Flood, J.F. and Morley, J.E., Age-related changes in footshock avoidance acquisition and retention in senescence accelerated mouse (SAM), Neurobiol. Aging., 14 (1993) 153-157.
54. Fraser, H., Eosinophilic bodies in some neurons in the thalamus of ageing mice, J. Pathol., 98 (1969) 201-204.
55. Fraser, H., Smith, W. and Gray, E.W., Ultrastructural morphology of cytoplasmic inclusions within neurons of ageing mice, J. Neurol. Sci., 11 (1970) 123-127.
56. Friend, W.C., Clapoff, S., Landry, C., Becker, L.E., O'Hanlon, D., Allore, R.J., Brown, I.R., Marks, A., Roder, J. and Dunn, R.J., Cell-specific expression of high levels of human S100β in transgenic mouse brain is dependent on gene dosage, J. Neurosci., 12 (1992) 4337-4346.
57. Fukuchi, K.-I., Ho, L., Younkin, S.G., Kunkel, D.D., Ogburn, C.E., LeBoeuf, R.C., Furlong, C.E., Deeb, S.S., Nochlin, D., Wegiel, J., Wisniewski, H.M. and Martin, G.M., High levels of circulating β-amyloid peptide do not cause cerebral β-amyloidosis in transgenic mice, Am. J. Pathol., 149 (1996) 219-227.
58. Funahashi, T., Floyd, R.A. and Carney, J.M., Age effect on brain pH during ischemia/reperfusion and pH influence on peroxidation, Neurobiol. Aging, 15 (1994) 161-167.
59. Gabellec, M.M., Griffains, R., Fillion, G. and Haour, F., Expression of interleukin 1 alpha, interleukin 1 beta and interleukin 1 receptor antagonist mRNA in mouse brain. Regulation by bacterial lipopolysaccharide treatment, Mol. Brain Res., 31 (1995) 122-130.
60. Games, D., Adams, D., Alessandrini, R., Barbour, R., Berthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., Guid, T., Hagoplan, S., Johnson-Wood, K., Khan, K., Lee, M., Leibowitz, P., Lieberburg, I., Little, S., Masilah, E., McConlogue, L., Montoya-Zavala, M., Mucke, L., Paganini, L., Penniman, E., Power, M., Schenk, D., Seubert, P., Snyder, B., Soriano, F., Tan, H., Vitale, J., Wadsworth, S., Wolozin, B. and Zhao, J., Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein, Nature, 373 (1995) 523-527.
61. Geinisman, Y., DeToledo-Morrell, L., Morrell, F., Heller, R.E., Hippocampal markers of age-related memory dysfunction: behavioral, electrophysiological and morphological perspectives, Prog. Neurobiol., 45 (1995) 223-252.
62. Gelman, R., Watson, A., Bronson, R. and Yunis, E., Murine chromosomal regions correlated with longevity, Genetics, 118 (1988) 693-704.
63. Gentleman, S.M., Graham, D.I. and Roberts, G.W., Molecular pathology of head trauma: altered beta APP metabolism and the aetiology of Alzheimer's disease, Prog. Brain Res., 96 (1993) 237-246.
64. Gerlai, R., Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype, TINS, 19 (1996) 177-182.
65. Gerlai, R., Wojtowicz, J.M., Marks, A. and Roder, J., Overexpression of a calcium-binding protein, S100β, in astrocytes alters synaptic plasticity and impairs spatial learning in transgenic mice, Learn. Mem., 2 (1995) 26-39.
66. Ginsberg, M.D. and Busto, R., Rodent models of cerebral ischemia, Stroke, 20 (1989) 1627-1642.
67. Gomi, H., Yokoyama, T., Fujimoto, K., Ikeda, T., Katoh, A., Itoh, T. and Itohara, S., Mice devoid of the glial fibrillary acidic protein develop normally and are susceptible to scrapie prions, Neuron, 14 (1995) 29-41.
68. Goodrick, C.L., Life-span and the inheritance of longevity of inbred mice, J. Gerontol., 30 (1975) 257-263.
69. Goodrick, C.L., Ingram, D.K., Reynolds, M.A., Freeman, J.R. and Cider, N., Effect of intermittent feeding upon body weight and lifespan in inbred mice. Interaction of genotype and age, Mech. Ageing Dev., 55 (1990) 69-87.
70. Goss, J.R. and Morgan, D.G., Enhanced glial fibrillary acidic protein RNA response to fornix transection in aged mice, J. Neurochem., 64 (1995) 1351-1360.
71. Gotti, B., Benavides, J., MacKenzie, E.T. and Scatton, B., The pharmacotherapy of focal cerebral ischemia in the mouse, Brain Res., 522 (1990) 290-307.
72. Götz, J., Probst, A., Spillantini, M.G., Schäfer, T., Jakes, R., Bürki, K. and Goedert, M., Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform, EMBO J., 14 (1995) 1304-1313.
73. Griffin, W.S.T., Stanley, L.C., Ling, C., White, L., MacLeod, V., Perrot, L.J., White, III, C.L. and Araoz, C., Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer's disease, Proc. Natl. Acad. Sci. USA, 86 (1989) 7611-7615.
74. Gundersen, H.J.G., Bagger, P., Bendtsen, T.F., Evans, S.M., Korbo, L., Marcussen, N., Moller, A., Nielsen, K., Nyengaard, J.R., Pakkenberg, B., Sorensen, F.B., Vesterby, A., and West, M.J., The new stereological tools: disector, fractionator, nu-cleator and point sampled intercepts and their use in pathological research and diagnosis, Acta Pathol. Microbiol. Immunol. Scand., 96 (1988) 857-881.
75. Gupta, M., Gupta, B.K., Thomas, R., Bruemmer, V., Sladek, Jr., J.R. and Felten, D.L., Aged mice are more sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment than young adults, Neurosci. Lett., 70 (1986) 326-331.
76. Halaas, J.L., Gajiwala, K.S., Maffei, M., Cohen, S.L., Chait, B.T., Rabinowitz, D., Lallone, R.L., Burley, S.K. and Friedman, J.M., Weight-reducing effects of the plasma protein encoded by the obese gene, Science, 269 (1995) 543-546.
77. Hallman, H.J., Lange, J., Olson, L., Stromberg, I. and Jonson, G., Neurochemical and histochemical characterization of neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurones in the mouse, J. Neurochem., 44 (1985) 117-127.
78. Hansen, L.A., Armstrong, D.M. and Terry, R.D., An immunohistochemical quantification of fibrous astrocytes in the aging human cerebral cortex, Neurobiol. Aging, 8 (1987) 1-6.
79. Harman, D., The aging process, Proc. Natl. Acad. Sci. USA, 78 (1981) 7124-7128.
80. Harrison, D.E., Commentary. Selection of longer-lived rodents, Growth Dev. Aging, 52 (1988) 207-211.
81. Harrison, D.E., Potential misinterpretations using models of accelerated aging, J. Gerontol., 49 (1994) B245-B246.
82. Harrison, D.E. and Archer, J.R., Physiological assays for biological age in mice: relation of collagen, renal function, and longevity, Exp. Aging Res., 9 (1983) 245-251.
83. Hartmann, P., Ramseier, A., Gudat, F., Mihatsch, M.J., Polasek, W. and Geisenhoff, C., Das Normalgewicht des Gehirns beim Erwachsenen in Abhängigkeit von Alter, Geschlecht, Körpergrösse und Gewicht, Pathologe, 15 (1994) 165-170.
84. Heikkila, R.E., Hess, A. and Duvoisin, R.C., Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice, Science, 224 (1984) 1451-1453.
85. Heumann, D. and Leuba, G., Neuronal death in the development and aging of the cerebral cortex of the mouse, Neuropathol. Appl. Neurobiol., 9 (1983) 297-311.
86. Higgins, L.S. and Cordell, B., Genetically engineered animal models of human neurodegenerative diseases, Neurodegeneration, 4 (1995) 117-129.
87. Higgins, L.S., Hotzman, D.M., Rabin, J., Mobley, W.C. and Cordell, B., Transgenic mouse brain histopathology resembles early Alzheimer's disease, Ann. Neurol., 35 (1994) 598-607.
88. Higgins, L.S., Rodems, J.M., Catalano, R., Quon, D. and Cordell, B., Early Alzheimer disease-like histopathology increases in frequency with age in mice transgenic for β-APP751, Proc. Natl. Acad. Sci. USA, 92 (1995) 4402-4406.
89. Himori, N., Watanabe, H., Akaike, N., Kurasawa, M., Itoh, J. and Tanaka, Y., Cerebral ischemia model with conscious mice: Involvement of NMDA receptor activation and derangement of learning and memory ability, J. Pharmacol. Methods, 23 (1990) 311-327.
90. Holtzman, D.M., Li, Y., DeArmond, S.J., McKinley, M.P., Gage, F.H., Epstein, C.J. and Mobley, W.C., Mouse model of neurodegeneration: Atrophy of basal forebrain cholinergic neurons in trisomic 16 transplants, Proc. Natl Acad. Sci. USA, 89 (1992) 1383-1387.
91. Holtzman, D.M., Santucci, D., Kilbridge, J., Chua-Couzens, J., Fontana, D.J., Daniels, S.E., Johnson, R.M., Chen, K., Sun, Y., Carlson, E., Alleva, E., Epstein, C.J. and Mobley, W.C., Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. Proc. Natl. Acad. Sci. USA, 93 (1996) 13333-13338.
92. Hornberger, J.C., Buell, S.J., Flood, D.G., McNeill, T.H. and Coleman, P.D., Stability of numbers but not size of mouse forebrain cholinergic neurons to 53 months, Neurobiol. Aging, 6 (1985) 269-275.
93. Howland, D.S., Savage, M.J., Huntress, F.A., Wallace, R.E., Schwartz, D.A., Loh, T., Melloni, Jr., R.H., Degennaro, L.J., Greenberg, B.D., Siman, R., Swanson, M.E. and Scott, R.W., Mutant and native human β-amyloid precursor proteins in transgenic mouse brain, Neurobiol. Aging, 16 (1995) 685-699
94. Hsiao, K.K., Borchelt, D.R., Olson, K., Johannsdottir, R., Kitt, C., Yunis, W., Xu, S., Eckman, C., Younkin, S., Price, D., Iadecola, C., Clark, H.B. and Carlson, G., Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precusor proteins, Neuron, 15 (1995) 1203-1218.
95. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F. and Cole, G., Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice, Science, 274 (1996) 99-102.
96. Hutchinson, E.W. and Rose. M.R., Quantitative genetic analysis of postponed aging in Drosophila melanogaster. In D. Harrison (Ed.), Genetic Effects of Aging II, 1988, Telford Press, Caldwell, NJ, pp. 65-86.
97. Ikegami, S., Shumiya, S. and Kawamura, H., Age-related changes in radial arm maze learning and basal forebrain cholinergic systems in senescence accelerated mice (SAM), Behav. Brain. Res., 51 (1992) 15-22.
98. Ingram, D.K., Effects of dietary restriction on brain and behavioral function in aging rodents. In Ingram, D.K., Baker, G.T. and Shock, N.S. (Eds.), The Potential for Nutritional Modulation of Aging Processes, 1991, Food and Nutrition Press, Westport, CN, pp. 289-310.
99. Ingram, D.K., Kuo, H., Hengemihle, J., Shimada, A., Tian, M. and Jucker, M., Motor and memory performance of SAM P8, R1 and C57BL/6 mice: Assessing the relationship to PAS-positive granules in brain. In Takeda, T. (Ed.), The SAM Model of Senescence, 1994, Elsevier, Amsterdam, pp. 73-82.
100. Ingram, D.K., Reynolds, M.A. and Les, P., The relationship of genotype, sex, body weight, and growth parameters to lifespan in inbred and hybrid mice, Mech. Ageing Dev., 20 (1982) 253-266.
101. Ingram, D.K., Wiener, H.L., Chachich, M.E., Long, J.M., Hengemihle, J. and Gupta, M., Chronic treatment of aged mice with L-deprenyl produces striatal MAO-B inhibition but no beneficial effects on survival, motor performance, or nigral lipofuscin accumulation, Neurobiol. Aging, 14 (1993) 431-440.
102. Irwin, I., Delanney, L.E., Langston, J.W., MPTP and aging. Studies in the C57BL/6J mouse, Adv. Neurol, 60 (1993) 197-206.
103. Irwin, I., Finnegan, K.T., Delanney, L.E., Di Monte, D. and Langston, J.W., The relationships between aging, monoamine oxidase, striatal dopamine and the effects of MPTP in C57BL/ 6J mice: A critical reassessment, Brain Res., 572 (1992) 224-231.
104. Johnson, H.A. and Erner, S., Neuron survival in the aged mouse, Exp. Gerontol., 7 (1972) 111-117.
105. Johnson, T.E., Friedman, D.B., Foltz, N., Fitzpatrick, P.A. and Shoemaker, J.E., Genetic variants and mutations of the caenorhabditis elegans provide tools for dissecting the aging process. In Harrison, D. (Ed.), Genetic Effects of Aging II, 1988, Telford Press, Caldwell, NJ, pp. 101-128.
106. Johnson, S.A., McNeill, T., Cordell, B. and Finch, C.E., Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease, Science, 248 (1990) 854-857.
107. Johnson, J.E., Mehler, W.R. and Miquel, J., A fine structural study of degenerative changes in the dorsal column nuclei of aging mice. Lack of protection by Vitamin E, J. Gerontol, 30 (1975) 395-411.
108. Jucker, M. and Ingram, D.K., Age-related fibrillar material in mouse brain: Assessing its potential as a biomarker of aging and as a model of human neurodegenerative disease, Ann. N. Y. Acad. Sci., 719 (1994) 238-247.
109. Jucker, M., Walker, L.C., Kuo, H., Tian, M. and Ingram, D.K., Age-related fibrillar deposits in brains of C57BL/6 mice: A review of localization, staining characteristics, and strain specificity, Mol. Neurobiol., 9 (1994) 125-133.
110. Jucker, M., Walker, L.C., Martin, L.J., Kitt, C.A., Kleinman, H.K., Ingram, D.K. and Price, D.L., Age-associated inclusions in normal and transgenic mouse brain, Science, 255 (1992) 1443-1445.
111. Jucker, M., Walker, L.C., Schwarb, P., Hengemihle, J., Kuo, H., Snow, A.D., Bamert, F. and Ingram, D.K., Age-related deposition of glia-associated fibrillar material in brains of C57BL/6 mice, Neuroscience, 60 (1994) 875-889.
112. Kammesheidt, A., Boyce, F.M., Spanoyannis, A.F., Cummings, B.J., Ortegon, M., Cotman, C., Vaught, J.L. and Neve, R.L., Deposition of β/A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of the Alzheimer amyloid precursor in the brain, Proc. Natl. Acad. Sci. USA, 89 (1992) 10 857-10 861.
113. Kato, K., Suzuki, F., Morishita, R., Asano, T. and Sato, T., Slecetive increase in S-100β protein by aging in rat cerebral cortex, J. Neurochem., 54 (1990) 1269-1274.
114. Katzman, R., Education and the prevalance of dementia and Alzheimer's disease, Neurology, 43 (1993) 13-20.
115. Kawabata, S., Higgins, G.A. and Gordon, J.W., Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing a C-terminal fragment of human amyloid precursor protein, Nature, 354 (1991) 476-478.
116. Kawabata, S., Higgins, G.A. and Gordon, J.W., Alzheimer's retraction, Nature, 356 (1992) 23.
117. Kawamata, T., Nakamura, S., Akiguchi, I., Kimura, J., Kameyama, M., Kimura, H. and Takeda, T., Effect of aging on NADPH-diaphorase neurons in laterodorsal tegmental nucleus and striatum of mice, Neurobiol. Aging, 11 (1990) 185-192.
118. Kawarabayashi, T., Shoji, M., Sato, M., Sasaki, A., Ho, L., Eckman, C.B., Prada, C.M., Younkin, S.G., Kobayashi, T., Tada, N., Matsubara, E., Iizuka, T., Harigaya, Y., Kasai, K. and Hirai, S., Accumulation of β-amyloid fibrils in pancreas of transgenic mice, Neurobiol. Aging, 17 (1996) 215-222.
119. Kier, A.B., Clinical neurology and brain histopathology in NZB/ NZW F1 lupus mice, J. Comp. Pathol., 102 (1990) 165-177.
120. Kinouchi, H., Epstein, C.J., Mizui, T., Carlson, E., Chen, S.F. and Chan, P.H., Attenuation of focal ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase, Proc. Natl. Acad. Sci. USA, 88 (1991) 11 158-11 162.
121. Kisilevsky, R., Inflammation-associated amyloidogenesis. Lessons for Alzheimer's amyloidogenesis, Mol. Neurobiol., 8 (1994) 65-66.
122. Kitado, H., Higuchi, K. and Takeda, T., Molecular genetic characterization of the senescenece-accelerated mouse (SAM) strains. J. Gerontol., 49 (1994) B247-B254.
123. Klein, S., Immunology: The Science of Self and Nonself Discrimination, 1982, Wiley, New York.
124. Kleyn, P.W., Fan, W., Kobats, S.G., Lee, J.J., Pulido, J.C., Wu, Y., Berkemeier, L.R., Misumi, D.J., Holmgren, L., Charlat, O., Woolf, E.A., Tayber, O., Brody, T., Shu, P., Hawkins, F., Kennedy, B., Balldini, L., Ebeling, C., Alperin, G.D., Deeds, J., Lakey, N.D., Culpepper, J., Culpepper, J., Chen, H., Glucksmann-Kuiss, M.A., Calson, G.A., Duyk, G.M. and Moore, K.J., Identification and characterization of the mouse obesity gene tubby: a member of a novel gene family, Cell, 85 (1996) 281-290.
125. Kohama, S.G., Goss, J.R., Finch, C.E. and McNeill, T.H., Increases of glial fibrillary acidic protein in the aging female mouse brain, Neurobiol. Aging, 16 (1995) 59-67.
126. Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H. and Kohler, G., Impaired immune and acute-phase responses in interleukin-6-deficient mice, Nature, 368 (1994) 339-342.
127. Kuo, H., Ingram, D.K., Walker, L.C., Tian, M., Hengemihle, J.M. and Jucker, M., Similarities of the age-related hippocampal deposition of PAS-positive granules in the senescence accelerated mouse P8 and C57BL/6 mouse strains, Neuroscience, 74 (1996) 733-740.
128. Lacey-Casem, M.L. and Oster-Granite, M.L., The neuropathology of the trisomy 16 mouse, Crit. Rev. Neurobiol., 8 (1994) 293-322.
129. LaFerla, F.M., Tinkle, B.T., Bieberich, C.J., Haudenschild, C.C. and Jay, G., The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice, Nature Genet., 9 (1995) 21-30.
130. Lai. F. and Williams, R.S., A prospective study of Alzheimer disease in Down Syndrome, Arch. Neurol., 46 (1989) 849-853.
131. Lamar, C.H., Hinsman, E.J. and Henrikson, C.K., Alterations in the hippocampus of aged mice, Acta Neuropathol., 36 (1976) 387-391.
132. Lamb, B.T., Sisodia, S.S., Lawler, A.M., Slunt, H.H., Kitt, C.A., Kearns, W.G., Pearson, P.L., Price, D.L. and Gearhart, J.D., Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice, Nature Genet., 5 (1993) 22-30.
133. Landfield, P.W., Waymire, J.C., Lynch, G., Hippocampal aging and adrenocorticoids: Quantitative correlations, Science, 202 (1978) 1098-1102.
134. Leuba, G., Aging of dendrites in the cerebral cortex of the mouse, Neuropathol. Appl. Neurobiol., 9 (1983) 467-475.
135. Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D.M., Oshima, J., Pettingell, W.H., Yu, C., Jondro, P.D., Schmidt, S.D., Wang, K., Crowley, A.C., Fu, Y.-H., Guenette, S.Y., Galas, D., Nemens, E., Wijsman, E.M., Bird, T.D., Schellenberg, G.D. and Tanzi, R.E., Candidate gene for the chromosome 1 familial Alzheimer's disease locus, Science, 269 (1995) 973-977.
136. Li, Y., Hunag, T.-T., Carlson, E.J., Melov, S., Ursell, P.C., Olson, J.L., Noble, L.J., Yoshimura, M.P., Berger, C., Chan, P.H., Wallace, D.C. and Epstein, C.J., Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase, Nature Genet., 11 (1995) 376-381.
137. Machado-Salas, J.P. and Scheibel, A.B., Limbic system of the aged mouse, Exp. Neurol., 63 (1979) 347-355.
138. Machado-Salas, J.P., Scheibel, M.E. and Scheibel, A.B., Morphological changes in the hypothalamus of the old mouse, Exp. Neurol., 57 (1977) 102-111.
139. Makar, T.K., Hungund, B.L., Cook, G.A., Kashfi, K. and Cooper, A.J., Lipid metabolism and membrane composition are altered in the brains of type II diabetic mice, J. Neurochem., 64 (1995) 2159-2168.
140. Malherbe, P., Richards, J.G., Martin, J.R., Bluethmann, H., Maggio, J. and Huber, G., Lack of β-amyloidosis in transgenic mice expressing low levels of familial Alzheimer's disease missense mutations, Neurobiol. Aging, 17 (1996) 205-214.
141. Mandybur, T.I., Ormsby, I. and Zemlan, F.P., Cerebral aging: a quantitative study of gliosis in old nude mice, Acta Neuropathol., 77 (1989) 507-511.
142. Martin, G.M., Austad, S.N. and Johnson, T.E., Genetic analysis of ageing: role of oxidative damage and environmental stresses, Nature Genet., 13 (1996) 25-34.
143. Masliah, E., Mallory, M., Ge, N., Alford, M., Veinberg, I. and Roses, A.D., Neurodegeneration in the central nervous system of apoE-deficient mice, Exp. Neurol., 136 (1995) 107-122.
144. Masliah, E., Mallory, M., Hansen, L., DeTeresa, R. and Terry, R.D., Quantitative synaptic alterations in the human neocortex during normal aging, Neurology, 43 (1993) 192-197.
145. Masters, C.L., Simms, G., Weinman, N.A., Multhaup, G., McDonald, B.L. and Beyreuther, K., Amyloid plaque core protein in Alzheimer's disease and Down Syndrome, Proc. Natl. Acad Sci. USA, 82 (1985) 4245-4249.
146. Masuoka, D.T., Jonsson, G. and Finch, C.E., Aging and unusual catecholamine-containing structures in the mouse brain, Brain Res., 169 (1979) 335-341.
147. McCall, M.A., Gregg, R.G., Behringer, R.R., Brenner, M., Delaney, C.L., Galbreath, E.J., Zhang, C.L., Pearce, R.A., Chiu, S.Y. and Messing, A., Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology, Proc. Natl. Acad. Sci. USA, 93 (1996) 6361-6366.
148. McGeer, P.L. and McGeer, E.G., The inflammatory response system of the brain: implications for therapy of Alzheimer and other neurodegenerative diseases, Brain Res. Rev., 21 (1995) 195-218.
149. McNeill, T.H., Davis, B.J., Hamill, R.W., Bresnahan, E.L. and Ingram, D.K., Assessment of lifelong caloric restriction on neostriatal morphology and peripheral neuroendocrine hormones in aged C57BL/6J mice. In D.K. Ingram, G.T. Baker and N.S. Shock (Eds.), The Potential for Nutritional Modulation of Aging Processes, 1991, Food and Nutrition Press, Westport, CN, pp. 2311-2326.
150. McNeill, T.H., Koek, L.L., Differential effects of advancing age on neurotransmitter cell loss in the substantia nigra and striatum of C57BL/6N mice, Brain Res., 521 (1990) 107-117.
151. McNeill, T.H., Koek, L.L., Brown, S.A. and Rafols, J.A., Quantitative analysis of age-related dendritic changes in medium spiny I (MSI) striatal neuron of C57BL/6N mice, Neurobiol. Aging, 11 (1990) 537-550.
152. McNeill, T., Koek, L.L. and Haycock, J.W., Age-correlated changes in dopaminergic nigrostriatal perikarya of the C57BL/ 6NNia mouse, Mech. Ageing Dev., 24 (1984) 293-307.
153. Mensah, P.L., Stability of large cell-medium cell clusters in the mature neostriatum, Exp. Brain Res., 47 (1982) 57-60.
154. Mesulam, M.M., Mufson, E.J. and Rogers, J., Age-related shrinkage of cortically projectiong cholinergic neurons: a selective effect, Ann. Neurol., 22 (1987) 31-36.
155. Miller, D.B., Bartke, A. and O'Callaghan, J.P., Increased glial fibrillary acidic protein (GFAP) levels in the brains of transgenic mice expressing the bovine growth hormone (bGH) gene, Exp. Gerontol., 30 (1995) 383-400.
156. Miller, M.M., Gould, B.E. and Nelson, J.F., Aging and long-term ovarieoctomy alter the cytoarchitecture of the hypothalamic-preoptic area of the C57BL/6J mouse, Neurobiol. Aging, 10 (1989) 683-690.
157. Miller, M.M., Joshi, D., Billiar, R.B. and Nelson, J.F., Loss of LH-RH neurons in the rostral forebrain of old female C57BL/ 6J mice, Neurobiol. Aging, 11 (1990) 217-221.
158. Miller, M.M., Joshi, D., Billiar, R.B. and Nelson, J.F., Loss during aging of beta-endorphinergic neurons in the hypothalamus of female C57BL/6J mice, Neurobiol. Aging, 12 (1991) 239-244.
159. Miller, M.M. and Zhu, L., Aging changes in the β-endorphin neuronal syatem in the preoptic area of the C57BL/6J mouse: Ultrastructural analysis, Neurobiol. Aging, 13 (1992) 773-781.
160. Mirault, M.-E., Tremblay, A., Furling, D., Trepanier, G., Dugre, F., Puymirat, J. and Pothier, F., Transgenic glutathione peroxidase mouse models for neuroprotective studies, Ann. NY Acad. Sci., 738 (1994) 104-115.
161. Miyamoto, M., Kiyota, Y., Yamazaki, N., Nagaoka, A., Matsuo, T., Nagawa, Y. and Takeda, T., Age-related changes in learning and memory in the senescence-accelerated mouse (SAM), Physiol. Behav., 38 (1986) 399-406.
162. Moran, P.M., Higgins, L.S., Cordell, B. and Moser, P.C., Age-related learning deficits in transgenic mice expressing the 751 amino acid isoform of human β-amyloid precursor protein, Proc. Natl. Acad. Sci. USA, 92 (1995) 5341-5345.
163. Morganti-Kossmann, M.C., Kossmann, T. and Wahl, S.M., Cytokines and neuropathology, TIPS, 13 (1992) 286-291.
164. Mouton, P.R., Pakkenberg, B., Gundersen, H.J.G. and Price, D.L., Absolute number and size of pigmented locus coeruleus neurons in young and aged individuals, J. Chem. Neuroanat., 7 (1994) 185-190.
165. Mrak, R.E., Sheng, J.G. and Griffin, W.S.T., Correlation of astrocytic S100β expression with dystrophic neuntes in amyloid plaques of Alzheimer's disease, J. Neuropathol. Exp. Neurol., 55 (1996) 273-279.
166. Mucke, L., Masliah, E., Johnson, W.B., Ruppe, M.D., Alford, M.,
167. Müller, U., Cristina, N., Li, Z.-W., Wolfer, D.P., Lipp, H.P., Rülicke, T., Brandner, S., Aguzzi, A. and Weissmann, C., Behavioral and anatomical deficits in mice homozygous for a modified β-amyloid precursor protein gene, Cell, 79 (1994) 755-765.
168. Myers, D.D., Review of disease patterns and life span in aging mice: Genetic and environmental interactions. In D. Bergsma and D.E. Harrison (Eds.), Genetic Effects on Aging, 1978, Liss, New York, pp. 41-53.
169. Nagai, J., Lin, C.Y. and Sabour, M.P., Lines of mice developed for reproductive longevity, Growth Dev. Aging, 59 (1995) 79-91.
170. Naggert, J.K., Fricker, L.D., Varlamov, O., Nishina, P.M., Rouille, Y., Steiner, D.F., Carroll, R.J., Paigen, B.J. and Leiter, E.H., Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity, Nature Genet., 10 (1995) 135-142.
171. Nakamura, S., Akiguchi, I., Seriu, N., Ohnishi, K., Takemura, M., Ueno, M., Tomimoto, H., Kawamata, T., Kimura, J. and Hosokawa, M., Monoamine oxidase-B-positive granular structures in the hippocampus of aged senescence-accelerated mouse (SAMP8), Acta Neuropathol., 90 (1995) 626-632.
172. Nandy, K., Brain-reactive antibodies in serum of aged mice, Prog. Brain Res., 40 (1973) 436-454.
173. Nandy, K., Lipofuscin as a marker of impaired homeostasis in aging organisms. In B.B. Davis and W.G. Wood (Eds.), Homeostatic Function and Aging, 1985, Raven Press, New York, pp. 139-148.
174. Nandy, K., Lal, H., Bennett, M. and Bennett, D., Correlation between a learning disorder and elevated brain-reactive antibodies in aged C57BL/6 and young NZB mice, Life Sci., 33 (1983) 1499-1503.
175. National Research Council, Mammalian Models for Research on Aging, 1981, National Academy Press, Washington DC.
176. Neve, R.L., Boyce, F.M., McPhie, D.L., Greenan, J. and Oster-Grantie, M.L., Transgenic mice expressing APP-C100 in the brain, Neurobiol, Aging, 17 (1996) 191-203.
177. Noben-Trauth, K., Naggert, J.K., North, M.A. and Nishina, P.M., A candidate gene for the mouse mutation on tubby, Nature, 380 (1996) 534-538.
178. Nyberg, P. and Waller, S., Age-dependent vulnerability of brain choline acetyltransferease activity to transient cerebral ischemia in rats, Stroke, 20 (1989) 495-500.
179. Ohlemiller, K.K., Hughes, R.M., Mosinger-Ogilvie, J., Speck, J.D., Grosof, D.H. and Silverman, M.S., Cochlear and retinal degeneration in the tubby mouse, Neuroreport, 6 (1995) 845-849.
180. Olanov, C.W., A radical hypothesis for neurodegeneration, TINS, 16 (1993) 439-444.
181. Orr, H.T. and Clark, H.B., Genetic approaches to pathogenesis of neurodegenertative diseases, Lab. Invest., 73 (1995) 161-171.
182. Orr, W.C. and Sohal, R.S., Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster, Science, 263 (1994) 1128-1130.
183. Paigen, K., A miracle enough: the power of mice, Nature Med., 1 (1995) 215-220.
184. Pearson, B.E. and Choi, T.K., Expression of the human β-amyloid precursor protein gene from a yeast artificial chromosome in transgenic mice, Proc. Natl. Acad. Sci. USA, 90 (1993) 10 578-10 582.
185. Pekny, M., Leveen, P., Pekna, M., Eliasson, C., Berthold, C.-H., Westermark, B. and Betsholtz, C., Mice lacking glial fibrillary acidic protein display astrocytes devoid of intermediate filaments but develop and reproduce normally, EMBO J., 14 (1995) 1590-1598.
186. Pelleymounter, M.A., Cullen, M.J., Baker, M.B., Hecht, R., Winters, D., Boone, T. and Collins, F., Effects of the obese gene product on body weight regulation in ob/ob mice, Science, 269 (1995) 540-543.
187. Pericak-Vance, M.A. and Haines, J.L., Genetic susceptibility to Alzheimer disease, Trends Genet., 11 (1995) 504-508.
188. Perlmutter, L.S. and Chui, H.C., Microangiopathy, the vascular basement membrane and Alzheimer's disease: A review, Brain Res. Bull., 24 (1990) 677-686.
189. Plump, A.S., Smith, J.D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J.G., Rubin, E.M. and Breslow, J.L., Severe hypercholesterolemia and artherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells, Cell, 71 (1992) 343-353.
190. Price, D.L., Cleveland, D.W. and Koliatsos, V.E., Motor neuron disease and animal models, Neurobiol. Dis., 1 (1994) 3-11.
191. Price, D.L., Walker, L.C., Martin, L.J. and Sisodia, S.S., Amyloidosis in aging and Alzheimer's disease, Am. J. Pathol., 141 (1992) 767-772.
192. Pulsinelli, W.A. and Brierley, B., A new model of bilateral hemispheric ischemia in the unanesthetized rat, Stroke, 10 (1979) 267-272.
193. Quon, D., Wang, Y., Catalano, R., Scardina, J.M., Murakami, K. and Cordell, B., Formation of β-amyloid protein deposits in brains of transgenic mice, Nature, 352 (1991) 239-241.
194. Rafols, J.A., Cheng, H.W. and McNeill, T.H., Golgi study of the mouse striatum: Age-related dendritic changes in different neuronal populations, J. Comp. Neurol., 279 (1989) 212-227.
195. Rakic, P. and Caviness Jr., V.S., Cortical development: View from neurological mutants: two decades later, Neuron, 14 (1995) 1101-1104.
196. Reaume, A.G., Elliott, J.L., Hoffman, E.K., Kowall, N.W., Ferrante, R.J., Siwek, D.F., Wilcox, H.M., Flood, D.G., Beal, M.F., Brown Jr., R.H., Scott, R.W. and Snider, W.D., Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury, Nature Genet., 13 (1996) 43-47.
197. Reeves, R.H., Irving, N.G., Moran, T.H., Wohn, A., Kitt, C., Sisodia, S.S., Schmidt, C., Bronson, R.T. and Davisson, M.T., A mouse model for Down syndrome exhibits learning and behaviour deficits, Nature Genet., 11 (1995) 177-183.
198. Reeves, R.H., Yao, J., Crowley, M.R., Buck, S., Zhang, X., Yarowsky, P., Gearhart, J.D. and Hilt, D.C., Astrocytosis and axonal proliferation in the hippocampus of S100β transgenic mice, Proc. Natl. Acad Sci. USA, 91 (1994) 5359-5363.
199. Reichel, W., Hollander, J., Clark, J.H. and Strehler, B.L., Lipofuscin pigment accumulation as a function of age and distribution in rodent brain, J. Gerontol., 23 (1968) 71-78.
200. Richards, S.J., Waters, J.J., Beyreuther, K., Masters, C.L., Wischik, C.M., Sparkman, D.R., White, III, C.L., Abraham, C.R. and Dunnett, S.B., Transplants of mouse trisomy 16 hippocampus provide a model of Alzheimer's disease neuropathology, EMBO J., 10 (1991) 297-303.
201. Roses, A.D., Apolipoprotein E affects the rate of Alzheimer Disease expression: β-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease, J. Neuropathol. Exp. Neurol., 53 (1994) 429-437.
202. Rosenzweig, M.R. and Bennett, E.L., Enriched environments: Facts, factors and fantasies. In J.L. McGaugh and L. Petrinovich (eds), Knowing, Thinking, Believing, 1976, Plenum, New York, pp. 234-246.
203. Russo, S.M., Daniels, A.J., Viveros, O.H. and Reinhard, Jr., J.F., Differences in the reserpine-sensitive storage in vivo of 1-methyl-4-phenylpyridinium in rats and mice may explain differences in catecholamine toxicity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Neurotoxicol. Teratol., 16 (1994) 277-281.
204. Sakaguchi, S., Katamine, S., Nishida, N., Moriuchi, R., Shigematsu, K., Sugimoto, T., Nakatani, A., Kataoka, Y., Houtani, T., Shirabe, S., Okada, H., Hasegawa, S., Miyamoto, T. and Noda, T., Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene, Nature, 380 (1996) 528-531.
205. Samorajski, T., Ordy, J.M. and Rady-Reimer, P., Lipofuscin pigment accumulation in the nervous system of aging mice, Anat. Rec., 160 (1968) 555-573.
206. Samorajski, T. and Rolsten, C., Age and regional differences in the chemical composition of brains of mice, monkeys and humans. In D.H. Ford (Ed.), Progress in Brain Research, Neurobiological Aspects of Maturation and Aging, Vol. 40, 1973, pp. 253-265.
207. Sandhu, F.A., Salim, M. and Zain, S.B., Expression of the human β-amyloid protein of Alzheimer's disease specifically in the brains of transgenic mice, J. Biol. Chem., 266 (1991) 21 331-21 334.
208. Sapolsky, R., Uno, H., Rebert, C. and Finch, C., Hippocampal damage associated with prolonged glucocorticoid exposure in primates, J. Neurosci., 10 (1990) 2897-2902.
209. Schellenberg, G.D., Genetic dissection of Alzheimer's disease, a heterogeneous disorder, Proc. Natl. Acad. Sci. USA, 92 (1995) 8552-8559.
210. Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T.D., Hardy, J., Hutton, M., Kukull, W., Larson, E., Levy-Lahad, E., Viitanen, M., Peskind, E., Poorkaj, P., Schellenberg, G., Tanzi, R., Wasco, W., Lannfelt, L., Selkoe, D. and Younkin, S., Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vitro by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease, Nature Med., 2 (1996) 864-870.
211. Schipper, H.M., Gomori-positive astrocytes: Biological properties and implications for neurological and neuroendocrine disorders, Glia, 4 (1991) 365-377.
212. Schipper, H., Brawer, J.R., Nelson, J.F., Felicio, L.S. and Finch, C.E., Role of the gonads in the histologic aging of the hypothalamic arcuate nucleus, Biol. Reprod., 25 (1981) 413-419.
213. Schrott, L.M., Denenberg, V.H., Sherman, G.F., Rosen, G.D. and Galaburda, A.M., Lashley maze learning deficits in NZB mice, Physiol. Behav., 52 (1992) 1085-1089.
214. Sekiguchi, M., Shimai, K., Moriya, M. and Nowakowski, R.S., Abnormalities of foliation and neuronal position in the cerebellum on NZB/BINJ mouse, Dev. Brain Res., 64 (1991) 189-195.
215. Selkoe, D.J., The molecular pathology of Alzheimer's disease, Neuron, 6 (1991) 487-498.
216. Sheng, J.G., Mrak, R.E., Rovnaghi, C.R., Kozlowska, E., Van Eldik, L.J. and Griffin, W.S.T., Human brain S100β and S100β mRNA expression increases with age: Pathogenic implications for Alzheimer's disease, Neurobiol. Aging, 17 (1996) 359-363.
217. Sheppard, M.C., Bailey, C.J., Flatt, P.R., Swanston-Flatt, S.K. and Shennan, K.I., Immunoreactive neurotensin in spontaneous syndromes of obesity and diabetes in mice, Acta Endocrinol., 108 (1985) 532-536.
218. Sherrington, R., Rogaev, E.I., Liang, Y., Rogaeva, E.A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J.F., Bruni, A.C., Montesi, M.P., Sorbi, S., Rainero, I., Pinessi, L., Nee, L., Chumakov, I., Pollon, D., Brookes, A., Sanseau, P., Polinsky, R.J., Wasco, W., Da Silva, H.A.R., Haines, J.L., Pericak-Vance, M.A., Tanzi, R.E., Roses, A.D., Fraser, P.E., Rommens, J.M. and St. George-Hyslop, P.H., Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease, Nature, 375 (1995) 754-760.
219. Sherman, G.F., Galaburda, A.M., Behan, P.O. and Rosen, G.D., Neuroanatomical anomalies in autoimmune mice, Acta Neuropathol., 74 (1987) 239-242.
220. Sherman, G.F., Stone, J.S., Rosen, G.D. and Galaburda, A.M., Neocortical VIP neurons are increased in the hemisphere containing focal cerebrocortical microdysgenesis in New Zealand Black mice, Brain Res., 532 (1990) 232-236.
221. Shibuki, K., Gomi, H., Chen, L., Bao, S., Kim, J.J., Wakatsuki, H., Fujisaki, T., Fujimoto, K., Katoh, A., Ikeda, T., Chen, C., Thompson, R.F. and Itohara, S., Deficient cerebellar long-term depression, impaired eyeblink conditioning, and normal motor coordination in GFAP mutant mice, Neuron, 16 (1996) 587-599.
222. Shimada, A., Ohta, A., Akiguchi, I. and Takeda, T., Inbred SAM-P/10 as a mouse model of spontaneous, inherited brain atrophy, J. Neuropathol. Exp. Neurol., 51 (1992) 440-450.
223. Shimada, A., Hosokawa, M., Ohta, A., Akiguchi, I. and Takeda, T., Localization of atrophy-prone areas in the aging mouse brain: Comparison between the brain atrophy model SAM-P/10 and the normal control SAM-R/1, Neurosci., 59 (1994) 859-869.
224. Smith, M.A., Sayre, L.M., Monnier, V.M. and Perry, G., Radical AGEing in Alzheimer's disease, TINS, 18 (1995) 172-176.
225. Snow, A.D. and Wight, T.N., Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses, Neurobiol. Aging, 10 (1989) 481-497.
226. Sotelo, C., Cerebellar synaptogenesis: What we can learn from mutant mice, J. Exp. Biol., 153 (1990) 225-249.
227. Spencer, Jr., D.G., Humphries, K., Mathis, D. and Lal, H., Behavioral impairments related to cognitive dysfunction in the autoimmune New Zealand black mouse, Behav. Neurosci., 100 (1986) 353-358.
228. Sprott, R.L., Development of animal models of aging at the National Institute on Aging, Neurobiol. Aging, 12 (1991) 635-638.
229. Stadtman, E.R., Protein oxidation and aging, Science, 257 (1992) 1220-1224.
230. Steel, K.P., Similarities between mice and humans with hereditary deafness, Ann. N. Y. Acad. Sci., 630 (1991) 68-79.
231. Steger, R.W., Bartke, A. and Cecim, M., Premature ageing in transgenic mice expressing different growth hormone genes, J. Reprod. Fert. Suppl., 46 (1993) 61-75.
232. Stoll, J., Balbo, A., Ault, B., Rapoport, S.I. and Fine, A., Long-term transplants of mouse trisomy 16 hippocampal neurons, a model for Down's syndrome, do not develop Alzheimer's disease neuropathology, Brain Res., 610 (1993) 295-304.
233. Strolin Benedetti, M. and Dostert, P., Monoamine oxidase, brain ageing and degenerative diseases, Biochem. Pharmacol., 38 (1989) 555-561.
234. Sturrock, R.R., A quantitative lifespan study of changes in cell number, cell division, and cell death in various regions of the mouse forebrain, Neuropathol. Appl. Neurobiol., 5 (1979) 433-456.
235. Sturrock, R.R., A comparative quantitative and morphological study of ageing in the mouse neostriatum, indusium griseum and anterior commissure, Neuropathol. Appl. Neurobiol., 6 (1980) 51-68.
236. Sturrock, R.R. and Rao, K.A., A quantitative histological study of neuronal loss from the locus coeruleus of ageing mice, Neuropathol. Appl. Neurobiol., 11 (1985) 55-60.
237. Sugiyama, H., Hainfellner, J.A., Lassmann, H., Indravasu, S. and Budka, H., Uncommon types of polyglucosan bodies in the human brain: distribution and relation to disease, Acta Neuropathol., 86 (1993) 484-490.
238. Sundstrom, E., Stromberg, I., Tsutsumi, T., Olson, L. and Jonsson, G., Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57BL/6J mice: Comparison with three other strains of mice, Brain Res., 405 (1987) 26-38.
239. Suzuki, N., Cheung, T.T., Cai, X.-D., Odaka, A., Otvos, L., Eckman, C., Golde, T.E. and Younkin, S.G., An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants, Science, 264 (1994) 1336-1340.
240. Takeda, T., Hosokawa, M. and Higuchi, K., Senescence-Accelerated Mouse (SAM): A novel murine model of accelerated senescence, J. Am. Geriatr. Soc., 39 (1991) 911-919.
241. Takeda, T., Hosokawa, M., Takeshita, S., Irino, M., Higuchi, K., Matsushita, T., Tomita, Y., Yasuhira, K., Hamamoto, H., Shimizu, K., Ishii, M. and Yamamuro, T., A new murine model of accelerated senescence, Mech. Ageing Dev., 17 (1981) 183-194.
242. Takemura, M., Nakamura, S., Akiguchi, I., Ueno, M., Oka, N., Ishikawa, S., Shimada, A., Kimura, J. and Takeda, T., β/A4 protein-like immunoreactive granular structures in the brain of senescence-accelerated mouse, Am. J. Pathol., 142 (1993) 1887-1897.
243. Tartaglia, L.A., Dembski, M., Weng, X., Deng, N., Culpepper, J., Devos, R., Richards, G.J., Campfield, L.A., Clark, F.T., Deeds, J., Muir, C., Sanker, S., Moriarty, A., Moore, K.J., Smutko, J.S., Mays, G.G., Woolf, E.A., Monroe, C.A. and Tepper, R.I., Identification and expression cloning of a leptin receptor, OB-R, Cell, 83 (1995) 1263-1271.
244. Terry, R.D., DeTeresa, R. and Hansen, L.A., Neocortical cell counts in normal human adult aging, Ann. Neurol., 21 (1986) 530-539.
245. Terry, R.D., Masliah, E., Salmon, D.P., Butters, N., DeTeresa, R., Hill, R., Hansen, L.A. and Katzman, R., Physical basis of cognitive alterations in Alzheimer's disease: Synaptic loss is the major correlate of cognitive impairment, Ann. Neurol., 30 (1991) 572-580.
246. van Duinen, S.G., Maat-Schieman, M.L.C., Bruijn, J.A., Haan, J. and Roos, R.A.C., Cortical tissue of patients with hereditary cerebral hemorrhage with amyloidosis (Dutch) contains various extracellular matrix deposits, Lab. Invest., 73 (1995) 183-189.
247. Walford, R.L., The Immunologic Theory of Aging, 1969, Wilkens and Wilkens, Baltimore.
248. Warren, J.M., Zerweck, C. and Anthony, A., Effects of environmental enrichment on old mice, Dev. Psychobiol., 15 (1982) 13-18.
249. Weihmuller, F.B., Hadjiconstantinou, M. and Bruno, J.P., Dissociation between biochemical and behavioral recovery in MPTP-treated mice, Pharmacol. Biochem. Behav., 34 (1989) 113-117.
250. Weinachter, S.N., Blavet, N., O'Donnell, R.A., MacKenzie, E.T., Rapin, J.R., Models of hypoxia and cerebral ischemia, Pharmacopsychiatry, 2 (1990) 94-97.
251. Weindruch, R. and Walford, R.L., The Retardation of Aging and Disease by Dietary Restriction, 1988, Charles C. Thomas, Springfield, IL.
252. West, M.J., New stereological methods for counting neurons, Neurobiol. Aging, 14 (1993) 275-285.
253. West, M.J., Regionally specific loss of neurons in the aging human hippocampus, Neurobiol. Aging, 14 (1993) 287-293.
254. Wiener, H., Hashim, A., Lajtha, A. and Sershen, H., Age and strain differences in monoamine oxidase B in mouse brain, Res. Commun. Psychol. Psychiat. Behav., 13 (1988) 306.
255. Wirak, D.O., Bayney, R., Ramabhadran, T.V., Fracasso, R.P., Hart, J.T., Hauer, P.E., Hsiau, P., Pekar, S.K., Scangos, G.A., Trapp, B.D. and Unterbeck, A.J., Deposits of amyloid β protein in the central nervous system of transgenic mice, Science, 253 (1991) 323-325.
256. Wirak, D.O., Bayney, R., Ramabhadran, T.Y., Fracasso, R.P., Hart, J.T., Hauer, P.E., Hsiau, P., Pekar, S.K., Scangos, G.A., Trapp, B.D. and Unterbeck, A.J., Deposits of amyloid β protein in the central nervous system of transgenic mice - Retraction, Science, 255 (1992) 1445.
257. Yagi, H., Irino, M., Matsushita, T., Katoh, S., Umezawa, M., Tsuboyama, T., Hosokawa, M., Akiguchi, I., Tokunaga, R. and Takeda, T., Spontanous spongy degeneration of the brain stem in SAM-P/8 mice: A newly developed memory-deficient strain, J. Neuropathol. Exp. Neurol., 48 (1989) 577-590.
258. Yagi, H., Katoh, S., Akiguchi, I. and Takeda, T., Age-related deterioration of ability of acquisition in memory and learning in senescence accelerated mouse: SAM-P/8 as an animal model of distrurbances in recent memory, Brain Res., 474 (1988) 86-93.
259. Yang, G., Chan, P.H., Chen, J., Carlson, E., Chen, S.F., Weinstein, P., Epstein, C.J. and Kamii, H., Human copper-zinc superoxide dismutase transgenic mice are highly resistent to reperfusion injury after focal cerebral injury, Stroke, 25 (1994) 165-170.
260. Zhang, S.H., Reddick, R.L., Piedrahita, J.A. and Maeda, N., Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E, Science, 258 (1992) 468-4475.
261. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L and Friedman, J.M., Positional cloning of the mouse obese gene and its human homologue, Nature, 372 (1995) 425-432.
262. Zheng, H., Jiang, M., Trumbauer, M.E., Sirinathsinghji, D.J.S., Hopkins, R., Smith, D.W., Heavens, R.P., Dawson, G.R., Boyce, S., Conner, M.W., Stevens, K.A., Slunt, H.H., Sisodia, S.S., Chen, H.Y. and Van der Ploeg, L.H.T., β-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity, Cell, 81 (1995) 525-531.